Rusan Pharma Limited - Company Profile

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 1994.
1994 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Rusan Pharma Limited

Rusan Pharma Limited, a active public limited company, was established on 15 March 1994 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1994PLC077069. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹4.84 Cr.

Formerly known as Rusan Pharma Private Limited. It upholds a compliant status. Employing 656 professional, Its leadership includes Kunal Navin Saxena (Managing Director), Balasaheb Annasaheb Patil (Whole-Time Director), Sandeep Verma (Director). Past directors included Dilipkumar Khandubhai Desai, Kunal Navin Saxena, Sandeep Verma. It holds ₹279.97 Cr open charges and ₹80.83 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 58-D, Government Industrial Estate Charkop, Kandivali West, Mumbai, Maharashtra, 400067.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230MH1994PLC077069

  • Registration Number

    077069

  • Incorporation Date

    15 March 1994

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹4.84 Cr

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.84 Cr
  • Company Age 32 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 279.97 Cr
  • Satisfied Charges ₹ 80.83 Cr
  • Revenue Growth **** 0.17%
  • Profit Growth **** -33.95%
  • Ebitda **** -20.66%
  • Net Worth 18.29%
  • Total Assets **** 18.81%
Company report

Rusan Pharma Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Rusan Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Rusan Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Kunal Navin Saxena Managing Director 05 Apr 2012 Current
Balasaheb Annasaheb Patil Whole-Time Director 17 Oct 2012 Current
Sandeep Verma Director 20 Mar 2023 Current
Navin Satyapal Sexena Director 15 Mar 1994 Current
Aakarsh Navin Saxena Whole-Time Director 10 Feb 2016 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 01 May 2014 Past
Pramod Abcsdd Director 05 May 2012 Past
Pramod Abcsdd Director 01 Apr 2019 Past
Pramod Abcsdd Director 19 Apr 2013 Past
Pramod Abcsdd Director 01 May 2015 Past
Pramod Abcsdd Whole-Time Director 15 Jun 2021 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Rusan Pharma.

Rusan Pharma Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.17% increase. The company also saw a substantial fall in profitability, with a 33.95% decrease in profit. The company's net worth Soared by an impressive increase of 18.29%.

Rusan Pharma revenue growth over time
Rusan Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 0.17%
*******
*******
*******
*******
Revenue from Operations
*******
 3.06%
*******
*******
*******
*******
Total Assets
*******
 18.81%
*******
*******
*******
*******
Profit or Loss
*******
 -33.95%
*******
*******
*******
*******
Net Worth
*******
 18.29%
*******
*******
*******
*******
EBITDA
*******
 -20.66%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Rusan Pharma?

In 2023, Rusan Pharma had a promoter holding of 99.99% and a public holding of 0.01%. The company had 1 Subsidiary and 6 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹2,799,700,000.00

Satisfied Charges

₹808,300,000.00

Charges Breakdown by Lending Institutions
  • Canara Bank : 169.13 Cr
  • Others : 72.50 Cr
  • State Bank Of India : 38.34 Cr
Latest Charge Details
Date Lender Amount Status
01 Dec 2025 Others ₹15.00 Cr Open
16 Dec 2022 Others ₹10.00 Cr Open
27 Jul 2022 Others ₹10.00 Cr Open
31 Aug 2021 Canara Bank ₹75.00 Cr Open
29 Sep 2020 Canara Bank ₹16.50 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Rusan Pharma?

Rusan Pharma has a workforce of 656 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Rusan Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rusan Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Rusan Pharma
Recent Activity within the Organization
  • Charges

    The activity A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101217018 was registered on 01 Dec 2025. was completed.

  • Annual General Meeting

    The activity Rusan Pharma Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Charges

    The activity A charge with Others of Rs. 21.00 Cr registered on 28 Dec 2015 with Charge ID 10614211 was modified on 25 Apr 2025. was completed.

  • Balance Sheet

    The activity Rusan Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I. was completed.

  • Charges

    The activity A charge registered on 28 Jun 2016 via Charge ID 100042892 with Syndicate Bank was fully satisfied on 30 Jan 2024. was completed.

  • Charges

    Progress on A charge registered on 20 Jul 2020 via Charge ID 100504641 with Canara Bank was fully satisfied on 01 Jan 2024. was documented.

Explore recent activity and updates - View Recent Activity

Recent News, Updates & Announcement

Explore news and more updates - View Recent News

Frequently Asked Questions
What is the CIN of Rusan Pharma Limited?

The CIN of Rusan Pharma Limited is U24230MH1994PLC077069.

Where is Rusan Pharma Limited headquartered?

Rusan Pharma Limited is headquartered at 58-D, Government Industrial Estate Charkop, Kandivali West, Mumbai, Maharashtra, 400067.

When was Rusan Pharma Limited incorporated?

Rusan Pharma Limited was incorporated on 15 March 1994.

Who are the current directors of Rusan Pharma Limited?

The current directors of Rusan Pharma Limited are

What is the primary industry of Rusan Pharma Limited?

The primary industry of Rusan Pharma Limited is Manufacturing.

Is Rusan Pharma Limited a listed company?

Rusan Pharma Limited is unlisted.

What is the capital structure of Rusan Pharma Limited?

The authorized capital of Rusan Pharma Limited is ₹5.00 Cr, and the paid-up capital is ₹4.84 Cr.

What is the compliance status of Rusan Pharma Limited?

The compliance status of Rusan Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available